Beijing, China

Ni Lin


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):

Title: Innovations in Psoriasis Treatment by Ni Lin

Introduction

Ni Lin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the treatment of psoriasis. His innovative approach utilizes advanced photodynamic therapy to enhance treatment efficacy.

Latest Patents

Ni Lin holds a patent for the use of α-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis. This invention focuses on employing photodynamic therapy, which is suitable for various types of psoriasis. The method utilizes a laser wavelength of 670 nm, ensuring high light sensitivity and fast photobleaching. It minimizes the potential toxic effects associated with traditional ultraviolet irradiation therapies. The preparation methods for this treatment include solutions, creams, nanomicelles, and microspheres, with options for both systemic and topical administration. The effectiveness of this treatment has been validated through studies on cell and animal models, achieving remarkable results.

Career Highlights

Ni Lin is affiliated with Beijing Guiqianjin Medical Science and Technology Co., Ltd. His work in this company has been pivotal in advancing psoriasis treatment methodologies. His innovative solutions have garnered attention in the medical community for their practicality and effectiveness.

Collaborations

Ni Lin has collaborated with notable colleagues, including Hanqing Liu and Aiping Wang. Their combined expertise has contributed to the development and validation of his innovative treatment methods.

Conclusion

Ni Lin's contributions to psoriasis treatment through innovative photodynamic therapy represent a significant advancement in medical science. His work continues to inspire further research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…